Pages

Tuesday, July 28, 2020

MindMed Completes Dosing 18-MC Phase 1 Study

 

MindMed Completes Dosing 18-MC Phase 1 StudyNEW YORK, July 28, 2020 /CNW/ -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has concluded dosing in a Phase 1 Single Ascending Dose (SAD) study of 18-MC.




from Yahoo Finance https://ift.tt/3g8zXTe

Next
Prev Post
Previous
Next Post
Gulf

About Gulf

Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.

No comments:
Write comments

Subscribe to Newsletter

Popular Posts

© Copyright 2015 World Daily Top News. Designed by Bloggertheme9 | Distributed By Gooyaabi Templates. Powered by Blogger.